Craft

Deltex Medical

Stock Price

£0

2024-10-29

Market Capitalization

£2 M

2024-09-26

Revenue

£2.1 M

FY, 2024

Deltex Medical Summary

Company Summary

Overview
Deltex Medical Group a medical technology company which produces blood monitoring and fluid management equipment for use in surgical operations. The company's main product, the ultrasound probe CardioQ-ODM, which measures the rate of blood flow from the heart, has been shown to reduce postoperative complications and reduce length of hospital stay. As a result, use of ODM during surgery has the proven potential to deliver both clinical and economic benefits.
Type
Public
Status
Active
Founded
1992
HQ
Chichester, GB | view all locations
Website
http://www.deltexmedical.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Andy Mears, Chief Executive, Director

    • David Moorhouse, Finance Director

      • Jim Caruso, VP Education

        • Natalie Wettler, Finance Director

          LocationsView all

          1 location detected

          • Chichester, England HQ

            United Kingdom

            Unit 5b, Terminus Rd

          Deltex Medical Financials

          Summary Financials

          Revenue (FY, 2024)
          £2.1M
          Gross profit (FY, 2024)
          £1.6M
          Net income (FY, 2024)
          (£1.8M)
          Cash (FY, 2024)
          £242.0K
          EBIT (FY, 2024)
          (£1.6M)
          Enterprise value
          $3.8M

          Footer menu